Alembic Pharmaceuticals Limited (aplltd) Secures USFDA Tentative Approval for Darolutamide Tablets, 300 Mg

Alembic Pharmaceuticals Limited (APLLTD) announced USFDA tentative approval for Darolutamide Tablets, 300 mg, with an estimated market size of US$ 3,155 million.